Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Advances in qPCR Europe

's Biography



, ,

Anders Ståhlberg, Ph.D. is working as principal investigater at the Cancer Center, Sahlgrenska Academy, University of Gothenburg in Sweden and is a co-founder of TATAA Biocenter, Gothenburg, Sweden. With a background in molecular biotechnology, stem cell biology and tumor biology, his primary research interest is to understand molecular mechanisms in tumor development and stem cell differentiation. Several tumor forms are studied, but focus is on human sarcomas characterized by the FET (FUS, EWSR1 and TAF15) fusion oncogenes. Characterization of tumor cells at the single-cell level is believed to improve current diagnostics and to advance our understanding of their origin and development. A. Ståhlberg has developed several strategies for gene expression profiling, especially at the single cell level.

  Image

Characterization of Tumor Cell Lines at Single-Cell Level

Tuesday, 4 September 2012 at 00:00

Add to Calendar ▼2012-09-04 00:00:002012-09-04 01:00:00Europe/LondonCharacterization of Tumor Cell Lines at Single-Cell Level SELECTBIOenquiries@selectbiosciences.com

In this presentation we will discuss how single-cell analysis can be used to gain detailed information about tumor cell types, biomarkers, cell differentiation and cell functions in clonal tumor cell lines.


Add to Calendar ▼2012-09-04 00:00:002012-09-05 00:00:00Europe/LondonAdvances in qPCR EuropeSELECTBIOenquiries@selectbiosciences.com